Skip to main content
PMC home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1991 Oct;57(10):3049–3051. doi: 10.1128/aem.57.10.3049-3051.1991

Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice.

S Pecquet 1, D Guillaumin 1, C Tancrede 1, A Andremont 1
PMCID: PMC183921  PMID: 1746964

Abstract

When healthy volunteers were given a daily dose of 3 x 10(8) life-dehydrated Saccharomyces cerevisiae cells for 5 days, the volunteers excreted 10(5) living yeast cells per g of feces at first, but the yeast cells disappeared within 5 days of the end of treatment. In gnotobiotic mice, S. cerevisiae administered alone colonized the intestinal tract but did not interfere with previous or subsequent colonization by a variety of potentially enteropathogenic microorganisms. When these microorganisms were present, the intestinal counts of S. cerevisiae were greatly reduced.

Full text

PDF
3049

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andremont A., Raibaud P., Tancrède C. Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora. J Infect Dis. 1983 Sep;148(3):579–587. doi: 10.1093/infdis/148.3.579. [DOI] [PubMed] [Google Scholar]
  2. Besnier M. O., Bourlioux P., Fourniat J., Ducluzeau R., Aumaitre A. Influence de l'ingestion de yogourt sur l'activité lactasique intestinale chez des souris axéniques ou holoxéniques. Ann Microbiol (Paris) 1983 Mar-Apr;134A(2):219–230. [PubMed] [Google Scholar]
  3. Best W. R. On the logarithmid transformation of intestinal bacterial counts. Am J Clin Nutr. 1970 Dec;23(12):1608–1609. doi: 10.1093/ajcn/23.12.1608. [DOI] [PubMed] [Google Scholar]
  4. Buts J. P., Bernasconi P., Van Craynest M. P., Maldague P., De Meyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res. 1986 Feb;20(2):192–196. doi: 10.1203/00006450-198602000-00020. [DOI] [PubMed] [Google Scholar]
  5. Chapoy P. Traitement des diarrhées aiguës infantiles: essai contrôlé de Saccharomyces boulardii. Ann Pediatr (Paris) 1985 Jun;32(6):561–563. [PubMed] [Google Scholar]
  6. Corthier G., Dubos F., Ducluzeau R. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol. 1986 Nov;32(11):894–896. doi: 10.1139/m86-164. [DOI] [PubMed] [Google Scholar]
  7. Ducluzeau R., Bellier M., Raibaud P. Transit Digestif de Divers Inoculums Bactériens Introduits "Per Os" Chez des Souris Axéniques et "Holoxéniques" (Conventionnelles): Effet Antagoniste de la Microflore du Tractus Gastro-Intestinal. Zentralbl Bakteriol Orig. 1970 May;213(4):533–548. [PubMed] [Google Scholar]
  8. Ducluzeau R., Bensaada M. Effet comparé de l'administration unique ou en continu de Saccharomyces boulardii sur l'établissement de diverses souches de Candida dans le tractus digestif de souris gnotoxéniques. Ann Microbiol (Paris) 1982 Nov-Dec;133(3):491–501. [PubMed] [Google Scholar]
  9. George W. L., Rolfe R. D., Finegold S. M. Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology. 1980 Aug;79(2):366–372. [PubMed] [Google Scholar]
  10. Harms H. K., Bertele-Harms R. M., Bruer-Kleis D. Enzyme-substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency. N Engl J Med. 1987 May 21;316(21):1306–1309. doi: 10.1056/NEJM198705213162104. [DOI] [PubMed] [Google Scholar]
  11. Pecquet S., Chachaty E., Tancrède C., Andremont A. Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice. Antimicrob Agents Chemother. 1991 Mar;35(3):548–552. doi: 10.1128/aac.35.3.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sinai Y., Kaplun A., Hai Y., Halperin B. Enhancement of resistance to infectious diseases by oral administration of brewer's yeast. Infect Immun. 1974 May;9(5):781–787. doi: 10.1128/iai.9.5.781-787.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Surawicz C. M., Elmer G. W., Speelman P., McFarland L. V., Chinn J., van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989 Apr;96(4):981–988. doi: 10.1016/0016-5085(89)91613-2. [DOI] [PubMed] [Google Scholar]
  14. Tempé J. D., Steidel A. L., Blehaut H., Hasselmann M., Lutun P., Maurier F. Prévention par saccharomyces boulardii des diarrhées de l'alimentation entérale à débit continu. Sem Hop. 1983 May 5;59(18):1409–1412. [PubMed] [Google Scholar]
  15. Toothaker R. D., Elmer G. W. Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii. Antimicrob Agents Chemother. 1984 Oct;26(4):552–556. doi: 10.1128/aac.26.4.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vidon N., Huchet B., Rambaud J. C. Influence de "Saccharomyces boulardii" sur la sécrétion jéjunale induite chez le rat par la toxine cholérique. Gastroenterol Clin Biol. 1986 Jan;10(1):13–16. [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES